CM
PAHC icon

CastleKnight Management’s Phibro Animal Health PAHC Stock Holding History

CastleKnight Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5M Buy
461,322
+385,427
+508% +$16.3M 0.2% 79
2026
Q1 		$4.2M Sell
75,895
-165,002
-68% -$7.85M 0.07% 190
2025
Q4 		$9M Sell
240,897
-158,886
-40% -$6.45M 0.2% 65
2025
Q3 		$16.2M Sell
399,783
-131,562
-25% -$4.35M 0.32% 44
2025
Q2 		$13.6M Buy
531,345
+113,600
+27% +$2.48M 0.38% 41
2025
Q1 		$8.92M Buy
417,745
+28,312
+7% +$633K 0.35% 46
2024
Q4 		$8.18M Buy
389,433
+22,796
+6% +$527K 0.24% 54
2024
Q3 		$8.26M Buy
366,637
+118,000
+47% +$2.28M 0.34% 34
2024
Q2 		$4.17M Buy
248,637
+152,300
+158% +$2.45M 0.21% 72
2024
Q1 		$1.25M Buy
96,337
+48,500
+101% +$581K 0.07% 178
2023
Q4 		$554K Hold
47,837
– – 0.03% 219
2023
Q3 		$611K Hold
47,837
– – 0.04% 220
2023
Q2 		$655K Buy
47,837
+4,137
+9% +$59.3K 0.07% 190
2023
Q1 		$669K Buy
+43,700
New +$668K 0.07% 164

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CastleKnight Management's PAHC Position: Q2 2026 in Review

CastleKnight Management increased its Phibro Animal Health (PAHC) stake by 508% in Q2 2026, buying an estimated $16.3M and bringing the position to 461,322 shares worth $14.5M. The position accounts for 0.2% of the portfolio, ranked #79.

CastleKnight Management first reported a position in PAHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $16.2M in Q3 2025. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • CastleKnight Management held 461,322 shares of Phibro Animal Health worth $14.5M as of Q2 2026.
  • CastleKnight Management bought 385,427 Phibro Animal Health shares in Q2 2026, an estimated $16.3M.
  • Phibro Animal Health made up 0.2% of CastleKnight Management's portfolio in Q2 2026, its #79 holding.
  • CastleKnight Management first reported a position in Phibro Animal Health in Q1 2023 and has held it in 14 quarters since.
  • CastleKnight Management's Phibro Animal Health position peaked at $16.2M in Q3 2025.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on CastleKnight Management's 13F filing for Q2 2026, filed 14 Aug 2026.